Loading…
Based on limited metadata, this FDA Warning Letter issued to DermaCare Biosciences, LTD. on December 1, 2021, concerns medical devices manufactured or distributed by the company. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's medical device regulatory authority, though the specific issuing office is not identified in this metadata. Further review of the complete warning letter would be necessary to identify the specific compliance issues cited.